Verrica Pharmaceuticals Stock Price Prediction
| VRCA Stock | USD 1.24 0.13 11.71% |
Oversold Vs Overbought
35
Oversold | Overbought |
EPS Estimate Next Quarter (0.28) | EPS Estimate Current Year (1.48) | EPS Estimate Next Year (0.67) | Wall Street Target Price 6.3333 | EPS Estimate Current Quarter (0.37) |
Using Verrica Pharmaceuticals hype-based prediction, you can estimate the value of Verrica Pharmaceuticals from the perspective of Verrica Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Verrica Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Verrica because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Verrica Pharmaceuticals after-hype prediction price | USD 1.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Verrica |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Verrica Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Verrica Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Verrica Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Verrica Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Verrica Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Verrica Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Verrica Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Verrica Pharmaceuticals' historical news coverage. Verrica Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.06 and 10.91, respectively. We have considered Verrica Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Verrica Pharmaceuticals is dangerous at this time. Analysis and calculation of next after-hype price of Verrica Pharmaceuticals is based on 3 months time horizon.
Verrica Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Verrica Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Verrica Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Verrica Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.37 | 9.70 | 0.03 | 0.11 | 9 Events / Month | 2 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.24 | 1.21 | 2.42 |
|
Verrica Pharmaceuticals Hype Timeline
Verrica Pharmaceuticals is at this time traded for 1.24. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.11. Verrica is forecasted to decline in value after the next headline, with the price expected to drop to 1.21. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.42%, whereas the daily expected return is at this time at -0.37%. The volatility of related hype on Verrica Pharmaceuticals is about 3316.24%, with the expected price after the next announcement by competition of 1.35. About 44.0% of the company outstanding shares are owned by insiders. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Verrica Pharmaceuticals recorded a loss per share of 1.84. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Verrica Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Verrica Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Verrica Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Verrica Pharmaceuticals' future price movements. Getting to know how Verrica Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Verrica Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CUE | Cue Biopharma | 0.02 | 8 per month | 5.91 | 0.11 | 20.27 | (11.51) | 67.78 | |
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.19) | 6.21 | (9.35) | 34.87 | |
| INBX | Inhibrx | 1.00 | 6 per month | 2.70 | 0.02 | 5.54 | (6.11) | 16.80 | |
| MOLN | Molecular Partners AG | (0.10) | 5 per month | 0.00 | (0.02) | 9.38 | (8.53) | 52.92 |
Verrica Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Verrica price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Verrica using various technical indicators. When you analyze Verrica charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Verrica Pharmaceuticals Predictive Indicators
The successful prediction of Verrica Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Verrica Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Verrica Pharmaceuticals based on analysis of Verrica Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Verrica Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Verrica Pharmaceuticals's related companies. | 2023 | 2024 (projected) | Graham Number | 3.81 | 4.61 | Receivables Turnover | 1.16 | 1.1 |
Story Coverage note for Verrica Pharmaceuticals
The number of cover stories for Verrica Pharmaceuticals depends on current market conditions and Verrica Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Verrica Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Verrica Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Verrica Pharmaceuticals Short Properties
Verrica Pharmaceuticals' future price predictability will typically decrease when Verrica Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Verrica Pharmaceuticals often depends not only on the future outlook of the potential Verrica Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Verrica Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 45.3 M | |
| Cash And Short Term Investments | 69.5 M |
Complementary Tools for Verrica Stock analysis
When running Verrica Pharmaceuticals' price analysis, check to measure Verrica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verrica Pharmaceuticals is operating at the current time. Most of Verrica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Verrica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verrica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Verrica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |